Saudi Chemical signs SAR 100 million agreement for Licensing rights of developed injections products

Saudi Chemical Company Holding (SCCH) through its subsidiary AJA Pharmaceutical Industries Ltd. (AJA Pharma) has entered into a definitive agreement with DR. Reddy’s Laboratories LTD.
The company stated on Tadawul that AJA Pharma will get Licensing rights for three (03) of Dr. Reddy’s developed injections products for registration and commercialization in the Kingdom of Saudi Arabia and other (GCC) countries.
Noting that the contract value is SAR 100 million and its duration is 5 years. Through this agreement, the company aims to forge a partnership with Dr. Reddy’s and discuss in future a tech-transfer of these products to be produced locally in Aja Pharma plant.